Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Neuropsychology. 2019 Dec 2;34(3):249–263. doi: 10.1037/neu0000602

Table 1.

Demographic and clinical characteristics of the six study groups.

HIV− HIV+
Variable Control (n=58) Control (n=27) Encoding II/Vis (n=30) Monitoring STOP (n=30) Cue Detect Tone (n=29) Combination All (n=29)
Demographic
 Age (yrs)* 60.6 (7.6) 57.9 (7.1) 57.0 (7.0) 58.6 (6.2) 54.7 (4.0) 57.2 (6.0)
 Education (yrs) 14.6 (2.5) 13.3 (2.5) 14.2 (2.7) 14.8 (2.7) 13.9 (2.9) 14.0 (2.8)
 Sex (% women)* 34.5 11.1 20.0 16.7 13.8 10.3
 Ethn (% Hispanic) 17.2 14.8 26.7 23.3 13.8 20.7
 Race (% White) 65.5 79.3 63.0 62.1 66.7 66.7
Psychiatric
 Substance 53.5 66.7 76.7 66.7 72.4 69.0
 Depression* 32.8 74.1 76.7 66.7 69.0 62.1
 Anxiety* 17.2 33.3 53.3 33.3 48.3 34.5
Neurocognitive
 Estimated VIQa 110 (16) 106 (15) 105 (13) 103 (14) 106 (14) 107 (16)
 NCIb (%) 24.1 38.5 37.9 50.0 22.2 14.8
Medical
 Comorbidities 1.6 (1.4) 2.3 (1.8) 2.1 (1.4) 2.2 (1.4) 2.0 (1.5) 2.4 (1.7)
 HIV Disease
  Duration (yrs) ----- 20.9 (8.22) 21.3 (8.9) 20.0 (8.9) 21.7 (8.7) 22.0 (8.4)
  Nadir CD4 ----- 147 (132) 174 (182) 209 (1550 146 (151) 260 (233)
  Current CD4 ----- 582 (228) 714 (349) 711 (226) 654 (264) 694 (392)
  AIDS ----- 76.9 73.3 56.7 65.5 65.5
  ART (%) ----- 96.0 90.0 93.1 100 82.8
  HIV RNA (%) 4.1 0.0 7.14 11.5 0

Note. AIDS = Acquired Immune Deficiency Syndrome; ART = antiretroviral therapy; Comorbidities refers to the number of medical diagnoses per the nursing evaluation (e.g., hypertension, diabetes, hepatitis C). Ethn = ethnicity; HIV = Human immunodeficiency virus; II/Vis = Implementation intentions and visualization; NCI = Neurocognitive impairment (per NIH Toolbox or CogState); STOP = Stop, Think, Organize, and Plan (i.e., context-free cueing)

a

n = 189.

b

n = 192.

*

p < .05